Biosimilars

Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

Shots: The recent collaboration was based on the Celltrion's previous agreemen...

Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

Shots: The P-I study evaluating PK & PD of proposed tocilizumab biosimilar DRL...

Samsung Bioepis Receives EC’s Marketing Authorization for Epysqli (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Hemoglobinuria

Samsung Bioepis Receives EC’s Marketing Authorization for Epysqli (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Hemoglobi...

Shots: The EC has granted marketing authorization for Epysqli, a biosimilar refere...

Lupin Collaborated with Enzene Biosciences to Launch Cetuximab in India

Lupin Collaborated with Enzene Biosciences to Launch Cetuximab in India

Shots: The companies collaborated to launch Cetuximab, the first biosimilar develo...

Sandoz Reports the EMA Acceptance of MAA for Proposed Biosimilar Denosumab

Sandoz Reports the EMA Acceptance of MAA for Proposed Biosimilar Denosumab

Shots: The EMA has accepted the MAA for the proposed biosimilar denosumab (Prolia...

Celltrion’s Yuflyma (biosimilar, adalimumab) Receives the US FDA’s Approval for Multiple Indications

Celltrion’s Yuflyma (biosimilar, adalimumab) Receives the US FDA’s Approval for Multiple Indications

Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar r...

Image